Western Pacific Wealth Management LP Has $113,000 Stock Position in Agilent Technologies, Inc. (NYSE:A)

by · The Cerbat Gem

Western Pacific Wealth Management LP raised its stake in Agilent Technologies, Inc. (NYSE:A – Free Report) by 59.6% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 758 shares of the medical research company’s stock after acquiring an additional 283 shares during the period. Western Pacific Wealth Management LP’s holdings in Agilent Technologies were worth $113,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Crewe Advisors LLC raised its position in Agilent Technologies by 114.8% in the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after buying an additional 101 shares during the last quarter. Livelsberger Financial Advisory acquired a new position in Agilent Technologies during the third quarter worth $28,000. Ridgewood Investments LLC acquired a new position in Agilent Technologies during the second quarter worth $29,000. Fortitude Family Office LLC increased its stake in Agilent Technologies by 68.3% in the 3rd quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock valued at $35,000 after buying an additional 95 shares during the last quarter. Finally, Ashton Thomas Private Wealth LLC bought a new position in shares of Agilent Technologies in the 2nd quarter valued at about $39,000.

Agilent Technologies Price Performance

Agilent Technologies stock opened at $139.63 on Friday. The stock’s fifty day moving average price is $139.64 and its two-hundred day moving average price is $138.18. The firm has a market cap of $40.12 billion, a PE ratio of 28.97, a price-to-earnings-growth ratio of 6.14 and a beta of 1.07. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. Agilent Technologies, Inc. has a one year low of $104.09 and a one year high of $155.35.

Agilent Technologies (NYSE:A – Get Free Report) last posted its quarterly earnings data on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.06. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same quarter in the prior year, the business posted $1.43 earnings per share. Agilent Technologies’s revenue was down 5.6% compared to the same quarter last year. As a group, research analysts expect that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st were given a dividend of $0.236 per share. The ex-dividend date of this dividend was Tuesday, October 1st. This represents a $0.94 annualized dividend and a yield of 0.68%. Agilent Technologies’s dividend payout ratio is currently 19.50%.

Insiders Place Their Bets

In related news, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the sale, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at $5,801,595. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. In related news, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the sale, the chief executive officer now owns 24,118 shares of the company’s stock, valued at $3,497,110. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the sale, the senior vice president now owns 40,011 shares in the company, valued at $5,801,595. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 11,995 shares of company stock worth $1,739,510 over the last three months.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. Wells Fargo & Company assumed coverage on Agilent Technologies in a report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 target price on the stock. TD Cowen upped their price target on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Bank of America lifted their price objective on shares of Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. Citigroup raised their target price on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Finally, Evercore ISI upped their price objective on Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, Agilent Technologies currently has an average rating of “Moderate Buy” and a consensus price target of $144.36.

Check Out Our Latest Stock Analysis on Agilent Technologies

About Agilent Technologies

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Featured Stories

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).